Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies

Background. Stopping immunosuppression in a transplant patient with donor-derived malignancy offers the theoretical benefit that reconstitution of the patient’s immune system will allow “rejection” of the malignancy, as the malignancy also originates from allogeneic tissue. However, this option exis...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dominic Amara, BA, Steven A. Wisel, MD, Hillary J. Braun, MD, Eric A. Collisson, MD, Terence Friedlander, MD, Giulia Worner, NP, Garret R. Roll, MD, Ryutaro Hirose, MD, Peter G. Stock, MD, PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer 2021-01-01
coleção:	Transplantation Direct
Acesso em linha:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001090
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!